Difficulty: Medium
Average Score: 77%
Practice
A pregnant woman has been taking a prescribed drug. Before her expected delivery date we start administering oral vitamin K supplements, and when the baby is born he is given an injection of vitamin K to reduce the risk of abnormal bleeding, caused by the drug-induced impairments of hepatic vitamin K-dependent clotting factors, in the newborn. Which could be the drug the woman has been received?
Correct answer
C
Rationale
The correct answer is C) Phenytoin. Phenytoin is an antiepileptic drug that can lead to impairments in hepatic vitamin K-dependent clotting factors in both the mother and the fetus. This drug-induced deficiency can increase the risk of abnormal bleeding in the newborn.
A) Bupropion is an antidepressant and smoking cessation aid, but it does not typically affect hepatic vitamin K-dependent clotting factors.
B) Methadone is an opioid used for pain management and opioid dependence treatment. While it can have effects on the newborn, it does not directly impact hepatic vitamin K-dependent clotting factors.
D) Naloxone is an opioid antagonist used for the treatment of opioid overdose. It does not interfere with hepatic vitamin K-dependent clotting factors.
Educationally, understanding the effects of medications on pregnancy and neonatal outcomes is crucial for healthcare professionals working with pregnant women. It highlights the importance of monitoring and managing medications during pregnancy to prevent adverse effects on both the mother and the newborn. This scenario underscores the significance of providing appropriate interventions, such as vitamin K supplementation, to mitigate potential risks associated with drug-induced impairments.
A) Bupropion is an antidepressant and smoking cessation aid, but it does not typically affect hepatic vitamin K-dependent clotting factors.
B) Methadone is an opioid used for pain management and opioid dependence treatment. While it can have effects on the newborn, it does not directly impact hepatic vitamin K-dependent clotting factors.
D) Naloxone is an opioid antagonist used for the treatment of opioid overdose. It does not interfere with hepatic vitamin K-dependent clotting factors.
Educationally, understanding the effects of medications on pregnancy and neonatal outcomes is crucial for healthcare professionals working with pregnant women. It highlights the importance of monitoring and managing medications during pregnancy to prevent adverse effects on both the mother and the newborn. This scenario underscores the significance of providing appropriate interventions, such as vitamin K supplementation, to mitigate potential risks associated with drug-induced impairments.